Navigation Links
Exercising Throat Muscles May Relieve Sleep Apnea
Date:5/8/2009

Workout regimen for the upper airway may improve sleep disorder symptoms, study finds

FRIDAY, May 8 (HealthDay News) -- Tongue and throat exercises may help people with mild to moderate obstructive sleep apnea (OSA) find relief, a new report says.

A three-month program helped reduce OSA severity by 40 percent in the test subjects and improved symptoms such as low oxygen saturation levels in blood, sleepiness, snoring and poor sleep quality, according to the findings in the second issue for May of the American Journal of Respiratory and Critical Care Medicine. Of the 10 moderate OSA sufferers who did the exercises, eight were reclassified afterward as having only a mild condition and two were upgraded to having no OSA.

"It was commonly thought among doctors that strengthening and toning oropharyngeal muscles would have no benefit to the patient during sleep, but a recent study showed that didgeridoo playing helped decrease snoring and OSA," study investigator Dr. Geraldo Lorenzi-Filho of the sleep laboratory at the University of Sao Paulo, Brazil, said in an American Thoracic Society news release. "This was a change of paradigm, and indicated that not everything you do during the day is lost during sleep."

For the study, 16 people diagnosed with mild to moderate OSA performed a daily and weekly regimen of tongue and pharyngeal exercises, while 15 other sufferers performed a placebo treatment of deep breathing and nasal rinsing with saline solution. The control group experienced no change in their condition, and neither group experienced a change in weight or body size, two factors in the cause of OSA.

"The muscles of the upper airways are extremely complex, and the mechanisms leading to OSA are far from being well understood," Lorenzi-Filho said. "A strong muscle may be working on the wrong direction and not necessarily helping to open the airways. The overall set of exercises we tested target th
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Are We Exercising Pain Away? Not So Much.
2. Best Selling Weight Loss Expert Finally Answers The Question: Can You Achieve Permanent Fat Loss By Eating More and Exercising Less?
3. Exercising Power to Lead Healthier Lives - 740,000 Participants Cast Votes for Challenger of Year
4. How much are you really exercising?
5. Exercising judgment: The psychology of fitness
6. Exercising our immune system
7. President of the Mississippi Eye, Ear, Nose and Throat Society Joins with Retasure to Prevent Vision Loss
8. New Sucrets(R) ICE Cools Sore Throat Pain
9. Integrated Beverage Group Launches Childrens Throat Cooler(R) in Canada
10. Integrated Beverage Group Launches Childrens Throat Cooler(R)
11. Newer radiation treatment easier for some throat cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Exercising Throat Muscles May Relieve Sleep Apnea
Exercising Throat Muscles May Relieve Sleep Apnea
Breaking Medicine Technology:Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 2Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 3Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 4Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 5Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 6Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 7Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 8Patient Enrollment Complete for Phase I II Clinical Trial for GALNS for Morquio A Syndrome 51451 1Patient Enrollment Complete for Phase I II Clinical Trial for GALNS for Morquio A Syndrome 51451 2Patient Enrollment Complete for Phase I II Clinical Trial for GALNS for Morquio A Syndrome 51451 3Patient Enrollment Complete for Phase I II Clinical Trial for GALNS for Morquio A Syndrome 51451 4Good Nutrition Can Fuel the Whole Family Even the Four Legged Members 51449 1Good Nutrition Can Fuel the Whole Family Even the Four Legged Members 51449 2Good Nutrition Can Fuel the Whole Family Even the Four Legged Members 51449 3Monitoring Circulating Tumor Cells With the CellSearch 28R 29 System Can Predict Prognosis in Metastatic Breast Cancer 12986 1Monitoring Circulating Tumor Cells With the CellSearch 28R 29 System Can Predict Prognosis in Metastatic Breast Cancer 12986 2Monitoring Circulating Tumor Cells With the CellSearch 28R 29 System Can Predict Prognosis in Metastatic Breast Cancer 12986 3Monitoring Circulating Tumor Cells With the CellSearch 28R 29 System Can Predict Prognosis in Metastatic Breast Cancer 12986 4
Other Medicine Technology:New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 2New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 3New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 4New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 6New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 7New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 8New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 9New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 10New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 11New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 12New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 13New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 14Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid(R) in Facial Augmentation 2Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid(R) in Facial Augmentation 3